# Karyopharm Therapeutics Inc.: Form 8-K, filed Feb 19, 2026

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 16:06 ET
- Period: 2026-02-18
- Accession: 0001193125-26-059349
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/kpti-20260218.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/kpti-20260218.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-059349. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.